Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease

NCT01108029 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease
Gait Disorders, Neurologic

Interventions

DRUG: memantine
DRUG: placebo

Sponsor

University Hospital, Lille